Učitavanje...

A96 ADALIMUMAB FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE

BACKGROUND: Maintenance of remission of Crohn’s disease (CD) is a clinically important goal, as disease relapse can negatively affect quality of life. AIMS: The objective of this systematic review was to assess the efficacy and safety of adalimumab for maintenance of remission in patients with quies...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Can Assoc Gastroenterol
Glavni autori: Townsend, C M, Cepek, J, Abbass, M, Nguyen, T, Parker, C E, MacDonald, J K, Feagan, B G, Jairath, V, Khanna, R
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512699/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.095
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!